Single molecule detection methods are becoming increasingly important for diagnostic applications. Practical Early detection of disease requires sensitivity down to the level of single copies of the targeted biomarkers. Of the candidate technologies that can address this need, solid-state nanopores show great promise as digital sensors for single-molecule detection. Here, we present work detailing the use of solid-state nanopores as downstream sensors for a PCR-based assay targeting group A streptococcus (strep A) which can be readily extended to detect any pathogen that can be identified with a short nucleic acid sequence. We demonstrate that with some simple modifications to the standard PCR reaction mixture, nanopores can be used to reliably identify strep A in clinical samples. We also discuss methodological best practices both for adapting PCR-based assays to solid-state nanopore readout as well as analytical approaches by which to decide on sample status.Molecular methods for infectious disease diagnostic are gradually being introduced into clinical use, and this trend will only accelerate because of the Covid-19 pandemic. [1][2][3][4] Many of these molecular tests typically employ a DNA amplification method to generate many copies of the target sequence and then rely on downstream optical sensors to detect a fluorescent signal generated by the presence of amplified nucleic acid products (i.e., amplicons) in the sample.However, the optical components and the use of dyes as labels, required for fluorescence-based detection, can impose some limitations on the cost, size, and robustness of the instrument or